Bilimsel çalışmalar

Doç. Dr. Ferhat Demir

101 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Defining Inactivity of Juvenile Spondyloarthropathies: Delphi Study Among Pediatric Rheumatology Academy ( PeRA ) From Türkiye

    International Journal of Rheumatic Diseases, 2026

    DOI 10.1111/1756-185x.70606 PMID 41821199 Kaynak: OpenAlex

  2. How Well Do the New EULAR/ACR Classification Criteria Capture Pediatric Chronic Nonbacterial Osteomyelitis? A Multicenter Pediatric Cohort Study

    Journal of Pediatric Orthopaedics, 2026

    DOI 10.1097/bpo.0000000000003280 PMID 41988740 Kaynak: OpenAlex

  3. Factors predicting the severity of gastrointestinal involvement in children with IgA vasculitis? A Turkish multicenter cohort study

    European Journal of Pediatrics, 2026

    DOI 10.1007/s00431-026-07162-4 PMID 42289526 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  4. Evaluating Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Using Real-World Data

    Children, 2026

    DOI 10.3390/children13101410 PMID 42940729 Açık erişimli tam metinKaynak: OpenAlex

  5. Cyclophosphamide treatment with a comparison in both pediatric rheumatology and pediatric nephrology practices

    Pediatric Rheumatology, 2025

    DOI 10.1186/s12969-025-01080-9 PMID 40069880 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  6. Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf221 PMID 40257440 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  7. Results of a Nationwide Multicenter Study in Childhood Sjögren Disease

    The Journal of Rheumatology, 2025

    DOI 10.3899/jrheum.2024-1048 PMID 40664482 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. Development and validation of a Pediatric Internationally agreed UltraSound Hip synovitis protocol (PIUS-hip), by the PReS imaging working party

    Pediatric Rheumatology, 2025

    DOI 10.1186/s12969-025-01134-y PMID 40797274 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  9. Demographic and Clinical Characteristics of Pediatric Uveitis Cases from a Referral Center in Turkey

    Ocular Immunology and Inflammation, 2025

    DOI 10.1080/09273948.2025.2546954 PMID 40792602 1 atıf (Europe PMC) Kaynak: OpenAlex

  10. Longitudinal assessment of disease burden in juvenile systemic lupus erythematosus: A multicenter study of activity and damage scores

    Lupus, 2025

    DOI 10.1177/09612033251386091 PMID 41021284 1 atıf (Europe PMC) Kaynak: OpenAlex

  11. Three-year follow up of canakinumab dose extension in children with colchicine resistant fasmilial Mediterranean fever: PeRA-RG Experience

    Rheumatology, 2025

    DOI 10.1093/rheumatology/keaf403 PMID 40748721 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  12. ÇOCUKLARDA PFAPA HASTALIĞINDA TONSILLEKTOMI GEREKLILIĞINI ÖNGÖREBILIR MIYIZ?

    Kocaeli Üniversitesi - AVESİS, 2025

    Açık erişimli tam metinKaynak: OpenAlex

  13. Is it possible to predict the need for tonsillectomy in children with PFAPA?

    Kocaeli Üniversitesi - AVESİS, 2025

    Kaynak: OpenAlex

  14. KRONİK BAKTERİYEL OLMAYAN OSTEOMYELİT İÇİN KONSENSÜS TEDAVİ PLANLARININ GERÇEK DÜNYA VERİLERİ KULLANILARAK DEĞERLENDİRİLMESİ

    Kocaeli Üniversitesi - AVESİS, 2025

    Kaynak: OpenAlex

  15. Description of the characteristics of the nailfold capillary structure in healthy children: a multi-centric study

    Rheumatology, 2024

    DOI 10.1093/rheumatology/keae296 PMID 38775407 11 atıf (Europe PMC) Kaynak: OpenAlex

  16. Exploring factors for predicting colchicine responsiveness in children with PFAPA

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05703-3 PMID 39085658 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  17. Development and validation of a pediatric internationally agreed ultrasound knee synovitis protocol (PIUS-knee) by the PReS imaging working party

    Pediatric Rheumatology, 2024

    DOI 10.1186/s12969-024-01029-4 PMID 39434153 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  18. Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

    Pediatric Rheumatology, 2024

    DOI 10.1186/s12969-023-00943-3 PMID 38167070 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  19. Evaluation of pediatric rheumatologists’ approach to rituximab use: a questionnaire study

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05654-9 PMID 38926187 5 atıf (Europe PMC) Kaynak: OpenAlex

  20. The journey of MEFV heterozygous children: with or without colchicine

    European Journal of Pediatrics, 2024

    DOI 10.1007/s00431-024-05887-8 PMID 39581919 4 atıf (Europe PMC) Kaynak: OpenAlex

  21. Consensus on transition care for juvenile idiopathic arthritis: a Delphi study with youth, caregivers, and health professionals

    Pediatric Rheumatology, 2024

    DOI 10.1186/s12969-024-01047-2 PMID 39695685 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  22. Hypermobility Spectrum Disorders, Functional Constipation and Voiding Dysfunction in School-Aged Children: Are They Related to Each Other?

    Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 2024

    DOI 10.47572/muskutd.1416077 Kaynak: OpenAlex

  23. Çocuklarda PFAPA Hasatlığında Kolşisin Yanıtını Öngörebilir Miyiz.

    Kocaeli Üniversitesi - AVESİS, 2024

    Kaynak: OpenAlex

  24. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

    Joint Bone Spine, 2023

    DOI 10.1016/j.jbspin.2023.105559 PMID 36858168 22 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  25. Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study

    Seminars in Arthritis and Rheumatism, 2023

    DOI 10.1016/j.semarthrit.2023.152209 PMID 37126983 16 atıf (Europe PMC) Kaynak: OpenAlex

  26. NLRP12-associated autoinflammatory disease: much more than the FCAS phenotype

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/kzggp3 PMID 37877365 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  27. Inflammatory comorbidities ın the largest pediatric Familial Mediterranean fever cohort: a multicenter retrospective study of Pediatric Rheumatology Academy (PeRA)-Research Group (RG)

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06802-6 PMID 37926798 9 atıf (Europe PMC) Kaynak: OpenAlex

  28. How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience

    Pediatric Rheumatology, 2023

    DOI 10.1186/s12969-023-00860-5 PMID 37475055 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  29. The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-023-06557-0 PMID 36826737 10 atıf (Europe PMC) Kaynak: OpenAlex

  30. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study

    Expert Opinion on Biological Therapy, 2023

    DOI 10.1080/14712598.2023.2282133 PMID 37970654 7 atıf (Europe PMC) Kaynak: OpenAlex

  31. Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/j611kr PMID 37497697 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  32. PREDICT-crFMF score: A novel model for predicting colchicine resistance in children with familial Mediterranean fever

    Modern Rheumatology, 2023

    DOI 10.1093/mr/road008 PMID 36680425 1 atıf (Europe PMC) Kaynak: OpenAlex

  33. Do the features of juvenile psoriatic arthritis change according to age? A comprehensive evaluation of the PeRA Research Group Registry

    Rheumatology, 2023

    DOI 10.1093/rheumatology/kead496 PMID 37725366 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  34. A clinical overview of paediatric sarcoidosis: Multicentre experience from Turkey

    Modern Rheumatology, 2023

    DOI 10.1093/mr/road050 PMID 37243724 4 atıf (Europe PMC) Kaynak: OpenAlex

  35. Comparison of Oral Health and Salivary Biomarkers in Children with Juvenile Idiopathic Arthritis and Healthy Individuals

    Nigerian Journal of Clinical Practice, 2023

    DOI 10.4103/njcp.njcp_169_23 PMID 38158346 1 atıf (Europe PMC) Kaynak: OpenAlex

  36. Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study

    The Turkish Journal of Pediatrics, 2023

    DOI 10.24953/turkjped.2021.1132 PMID 36866986 3 atıf (Europe PMC) Kaynak: OpenAlex

  37. Clinical characteristics and predictors for recurrence in chronic nonbacterial osteomyelitis: a retrospective multicenter analysis

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2023

    DOI 10.55730/1300-0144.5675 PMID 38813038 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  38. Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience

    Pediatric Rheumatology, 2023

    DOI 10.1186/s12969-023-00925-5 PMID 37996934 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  39. Evaluation of common NLRP3 Q703K variant in pediatric patients with autoinflammatory disease: CAPS and PFAPA

    The Turkish Journal of Pediatrics, 2023

    DOI 10.24953/turkjped.2023.166 PMID 37661680 2 atıf (Europe PMC) Kaynak: OpenAlex

  40. Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort

    Frontiers in Pediatrics, 2022

    DOI 10.3389/fped.2021.805919 PMID 35127599 59 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  41. Real-life data on efficacy and safety of original Adalimumab and biosimilar Adalimumab (ABP 501) in pediatric rheumatic diseases

    Expert Opinion on Biological Therapy, 2022

    DOI 10.1080/14712598.2022.2123703 PMID 36101926 11 atıf (Europe PMC) Kaynak: OpenAlex

  42. Cluster analysis of paediatric Behçet’s disease: Data from The Pediatric Rheumatology Academy-Research Group

    Modern Rheumatology, 2022

    DOI 10.1093/mr/roac044 PMID 35534229 12 atıf (Europe PMC) Kaynak: OpenAlex

  43. Diagnosing growing pains in children by using machine learning: a cross-sectional multicenter study

    Medical & Biological Engineering & Computing, 2022

    DOI 10.1007/s11517-022-02699-6 PMID 36264529 10 atıf (Europe PMC) Kaynak: OpenAlex

  44. Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience

    Archives of Rheumatology, 2022

    DOI 10.46497/archrheumatol.2022.8998 PMID 36589607 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  45. The Multifaceted Presentation of the Multisystem Inflammatory Syndrome in Children: Data from a Cluster Analysis

    Journal of Clinical Medicine, 2022

    DOI 10.3390/jcm11061742 PMID 35330065 9 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  46. Risk Factors for Ocular Complications and Visual Loss in Patients with Juvenile Idiopathic Arthritis-associated Uveitis at a Turkish Tertiary Ophthalmology and Pediatric Rheumatology Referral Center

    Ocular Immunology and Inflammation, 2022

    DOI 10.1080/09273948.2022.2123833 PMID 36170554 3 atıf (Europe PMC) Kaynak: OpenAlex

  47. Is it all about age? Clinical characteristics of Kawasaki disease in the extremely young: PeRA research group experience

    Postgraduate Medicine, 2022

    DOI 10.1080/00325481.2022.2058206 PMID 35324413 1 atıf (Europe PMC) Kaynak: OpenAlex

  48. AB1264 CLINICAL, DEMOGRAPHIC CHARACTERISTICS AND TREATMENT RESPONSES OF PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME

    Annals of the Rheumatic Diseases, 2022

    DOI 10.1136/annrheumdis-2022-eular.5013 Açık erişimli tam metinKaynak: OpenAlex

  49. Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis

    Clinical and Experimental Rheumatology, 2021

    DOI 10.55563/clinexprheumatol/r4gnxm PMID 33635217 12 atıf (Europe PMC) Kaynak: OpenAlex

  50. SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center

    Archives of Rheumatology, 2021

    DOI 10.46497/archrheumatol.2021.8603 PMID 34870170 11 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex